Across Asia, a convergence of economic trends, government policies and greater awareness among the general public of healthcare issues has created an environment that is poised for dramatic growth and change.
The opportunities for Asia's healthcare organizations to forge new partnerships and collaborations, both inside and outside of traditional boundaries, are vast as countries throughout the region search for the best way to finance, organize and deliver healthcare with the right balance of quality, cost and access.
Taiwan has one of Asia's most highly-praised healthcare systems with excellent provision of healthcare and key health outcomes. Nevertheless, the government is facing new pressures for public healthcare reforms as result of a rapidly ageing population, rising healthcare costs, and financial imbalances in its National Health Insurance programme. Taiwan's healthcare organizations also face a dynamic operating environment where they must respond quickly to changes in the marketplace in order to survive and grow.
This paper provides an introductory overview of Taiwan's healthcare sector - including the healthcare services, pharma and medical device industries - and highlights the challenges and opportunities for market participants. It is based on a combination of face-to-face interviews, with prominent Taiwan healthcare experts in both the public and private sectors, and secondary research covering a broad range of sources.
If you would like to discuss any of the issues raised in this paper, please feel free to contact PwC's dedicated healthcare team (see page 34) who are well placed to help you meet the challenges and opportunities of the Taiwan marketplace.